Literature DB >> 29562192

Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape.

Max D Wellenstein1, Karin E de Visser2.   

Abstract

Owing to their tremendous diversity and plasticity, immune cells exert multifaceted functions in tumor-bearing hosts, ranging from anti-tumor to pro-tumor activities. Tumor immune landscapes differ greatly between and within cancer types. Emerging evidence suggests that genetic aberrations in cancer cells dictate the immune contexture of tumors. Here, we review the current understanding of the mechanisms whereby common drivers of tumorigenesis modulate the tumor immune milieu. We discuss these findings in the context of clinical observations and examine how cancer-cell-intrinsic properties can be exploited to maximize the benefit of immunomodulatory therapies. Understanding the relationship between cancer cell-intrinsic genetic events and the immune response may enable personalized immune intervention strategies for cancer patients.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29562192     DOI: 10.1016/j.immuni.2018.03.004

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  167 in total

Review 1.  The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers.

Authors:  Élora Midavaine; Jérôme Côté; Philippe Sarret
Journal:  Cancer Metastasis Rev       Date:  2021-05-11       Impact factor: 9.264

2.  Sticking together helps cancer to spread.

Authors:  Mikala Egeblad; Karin E de Visser
Journal:  Nature       Date:  2019-02       Impact factor: 49.962

3.  Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein.

Authors:  Enyong Dai; Leng Han; Jiao Liu; Yangchun Xie; Guido Kroemer; Daniel J Klionsky; Herbert J Zeh; Rui Kang; Jing Wang; Daolin Tang
Journal:  Autophagy       Date:  2020-01-16       Impact factor: 16.016

Review 4.  The interplay between innate and adaptive immunity in cancer shapes the productivity of cancer immunosurveillance.

Authors:  Renee B Chang; Gregory L Beatty
Journal:  J Leukoc Biol       Date:  2020-04-09       Impact factor: 4.962

5.  LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence.

Authors:  Kyle G Mitchell; Edwin R Parra; Jiexin Zhang; David B Nelson; Erin M Corsini; Pamela Villalobos; Cesar A Moran; Ferdinandos Skoulidis; Ignacio I Wistuba; Junya Fujimoto; Jack A Roth; Mara B Antonoff
Journal:  Ann Thorac Surg       Date:  2020-05-19       Impact factor: 4.330

6.  Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas.

Authors:  S Derks; L K de Klerk; X Xu; T Fleitas; K X Liu; Y Liu; F Dietlein; C Margolis; A M Chiaravalli; A C Da Silva; S Ogino; F G Akarca; G J Freeman; S J Rodig; J L Hornick; E van Allen; B Li; S X Liu; V Thorsson; A J Bass
Journal:  Ann Oncol       Date:  2020-05-06       Impact factor: 32.976

7.  Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2).

Authors:  Nune Markosyan; Jinyang Li; Yu H Sun; Lee P Richman; Jeffrey H Lin; Fangxue Yan; Liz Quinones; Yogev Sela; Taiji Yamazoe; Naomi Gordon; John W Tobias; Katelyn T Byrne; Andrew J Rech; Garret A FitzGerald; Ben Z Stanger; Robert H Vonderheide
Journal:  J Clin Invest       Date:  2019-06-04       Impact factor: 14.808

Review 8.  The p53 Saga: Early Steps in the Development of Tumor Immunotherapy.

Authors:  Albert B DeLeo; Ettore Appella
Journal:  J Immunol       Date:  2020-05-01       Impact factor: 5.422

9.  Regulatory T Cells Support Breast Cancer Progression by Opposing IFN-γ-Dependent Functional Reprogramming of Myeloid Cells.

Authors:  Nicholas M Clark; Leandro M Martinez; Steven Murdock; James T deLigio; Amy L Olex; Comfort Effi; Mikhail G Dozmorov; Paula D Bos
Journal:  Cell Rep       Date:  2020-12-08       Impact factor: 9.423

Review 10.  Not all cancers are created equal: Tissue specificity in cancer genes and pathways.

Authors:  Joy J Bianchi; Xin Zhao; Joseph C Mays; Teresa Davoli
Journal:  Curr Opin Cell Biol       Date:  2020-02-21       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.